The association between environmental exposures to chlordanes, adiposity and diabetes-related features: a systematic review and meta-analysis.

Vânia Mendes, Cláudia Ribeiro, Inês Delgado, Bárbara Peleteiro, Martine Aggerbeck, Emilie Distel, Isabella Annesi-Maesano, Denis Sarigiannis, Elisabete Ramos

Journal: Scientific reports 2021;11(1):14546

PMID: 34267268

Plain Language Summary

plain language summary logo

Chlordane is a synthetic organochlorine pesticide used for several decades in agriculture, but also in housing for pest control. Chlordane compounds are endocrine disrupting chemicals (EDCs), which means that they may affect the natural function of hormones by blocking, mimicking, displacing, or acting to subvert their roles. The aim of this study was to investigate whether exposure to chlordane compounds increases the risk of adiposity and diabetes in humans. This study is a systematic review and meta-analysis of 31 publications. Results demonstrate that there is no association between chlordane compounds and adiposity. However, there are higher odds of having diabetes-related features with increasing levels of all the chlordane compounds evaluated. Authors conclude that an international agreement on methods to measure both exposure and outcome variables and to conduct epidemiological studies could increase the knowledge on how adverse effects of exposure to various stressors (exposome) can influence human health.

Abstract

Chlordane compounds (CHLs) are components of technical chlordane listed in the Stockholm convention on persistent organic pollutants identified as endocrine disrupting chemicals (EDCs) and may interfere with hormone biosynthesis, metabolism or action resulting in an unbalanced hormonal function. There is increasing scientific evidence showing EDCs as risk factors in the pathogenesis and development of obesity and obesity-related metabolic syndromes such as type 2 diabetes, but there is no systematized information on the effect of CHLs in humans. Our aim is to identify the epidemiological data on the association between CHLs with adiposity and diabetes using a systematic approach to identify the available data and summarizing the results through meta-analysis. We searched PubMed and Web of Science from inception up to 15 February 2021, to retrieve original data on the association between chlordanes, and adiposity or diabetes. For adiposity, regression coefficients and Pearson or Spearman correlation coefficients were extracted and converted into standardized regression coefficients. Data were combined using fixed effects meta-analyses to compute summary regression coefficients and corresponding 95% confidence intervals (95% CI). For the association between chlordanes and diabetes, Odds ratios (ORs) were extracted and the DerSimonian and Laird method was used to compute summary estimates and respective 95% CI. For both, adjusted estimates were preferred, whenever available. Among 31 eligible studies, mostly using a cross-sectional approach, the meta-analysis for adiposity was possible only for oxychlordane and transchlordane, none of them were significantly associated with adiposity [(β = 0.04, 95% CI 0.00; 0.07, I = 89.7%)] and (β = 0.02, 95% CI - 0.01; 0.06), respectively. For diabetes, the estimates were positive for all compounds but statistically significant for oxychlordane [OR = 1.96 (95% CI 1.19; 3.23)]; for trans-nonachlor [OR = 2.43 (95% CI 1.64; 3.62)] and for heptachlor epoxide [OR = 1.88 (95% CI 1.42; 2.49)]. Our results support that among adults, the odds of having diabetes significantly increase with increasing levels of chlordanes. The data did not allow to reach a clear conclusion regarding the association with adiposity.

© 2021. The Author(s).

Address: ISPUP-EPIUnit, Institute of Public Health, Universidade do Porto, Rua das Taipas, nº135, 4050-600, Porto, Portugal.; ISPUP-EPIUnit, Institute of Public Health, Universidade do Porto, Rua das Taipas, nº135, 4050-600, Porto, Portugal.; Departamento de Ciências da Saúde Pública e Forenses, e Educação Médica da Faculdade de Medicina da Universidade do Porto, Al. Prof. Hernâni Monteiro, 4200-319, Porto, Portugal.; INSERM UMR-S 1124, 45 rue des Saints Pères, 75006, Paris, France.; Université de Paris, 45 rue des Saints Pères, 75006, Paris, France.; Sorbonne Université and INSERM, Epidemiology of Allergic and Respiratory Diseases Department (EPAR), Pierre Louis Institute of Epidemiology and Public Health (IPLESP UMRS 1136), Saint-Antoine Medical School, Paris, France.; Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece.; ISPUP-EPIUnit, Institute of Public Health, Universidade do Porto, Rua das Taipas, nº135, 4050-600, Porto, Portugal. [email protected].; Departamento de Ciências da Saúde Pública e Forenses, e Educação Médica da Faculdade de Medicina da Universidade do Porto, Al. Prof. Hernâni Monteiro, 4200-319, Porto, Portugal. [email protected].

Patient Centred Factor

Physical Environment

Clinical Imbalances

Modifiable Lifestyle Factors

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.